PeptideDB

Flurofamide 70788-28-2

Flurofamide 70788-28-2

CAS No.: 70788-28-2

Flurofamide is a potent bacterial urease inhibitor and may be utilized in research on infectious urinary tract stones.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Flurofamide is a potent bacterial urease inhibitor and may be utilized in research on infectious urinary tract stones.

Physicochemical Properties


Molecular Formula C7H9FN3O2P
Molecular Weight 217.14
Exact Mass 217.042
CAS # 70788-28-2
PubChem CID 51173
Appearance White to off-white solid powder
Density 1.457g/cm3
Index of Refraction 1.574
LogP 2.372
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 2
Heavy Atom Count 14
Complexity 260
Defined Atom Stereocenter Count 0
SMILES

c1cc(ccc1C(=O)NP(=O)(N)N)F

InChi Key QWZFVMCWPLMLTL-UHFFFAOYSA-N
InChi Code

InChI=1S/C7H9FN3O2P/c8-6-3-1-5(2-4-6)7(12)11-14(9,10)13/h1-4H,(H5,9,10,11,12,13)
Chemical Name

N-diaminophosphoryl-4-fluorobenzamide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References [1]. Millner OE Jr, et al. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones. J Urol. 1982 Feb;127(2):346-50.
Additional Infomation N-diaminophosphoryl-4-fluorobenzamide is an organohalogen compound and a carbonyl compound.

Solubility Data


Solubility (In Vitro) DMSO : 14.29 mg/mL (65.81 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 1.43 mg/mL (6.59 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 14.3 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 1.43 mg/mL (6.59 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 14.3 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 1.43 mg/mL (6.59 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 14.3 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.6053 mL 23.0266 mL 46.0532 mL
5 mM 0.9211 mL 4.6053 mL 9.2106 mL
10 mM 0.4605 mL 2.3027 mL 4.6053 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.